Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
CRNC Quote, Financials, Valuation and Earnings
Last price:
$9.51
Seasonality move
:
-9.71%
Day range:
$8.63 - $9.21
52-week range:
$2.34 - $27.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.60x
P/B ratio:
2.65x
Volume:
1.6M
Avg. volume:
2M
1-year change:
185.05%
Market cap:
$395.8M
Revenue:
$331.5M
EPS (TTM):
-$8.10
Analysts' Opinion
-
Consensus RatingCerence has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $11.60, Cerence has an estimated upside of 26.78% from its current price of $9.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.00 representing 1.64% downside risk from its current price of $9.15.
Fair Value
-
According to the consensus of 5 analysts, Cerence has 26.78% upside to fair value with a price target of $11.60 per share.
CRNC vs. S&P 500
-
Over the past 5 trading days, Cerence has underperformed the S&P 500 by -8.65% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cerence does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cerence has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Cerence reported revenues of $78M.
Earnings Growth
-
Cerence earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Cerence reported earnings per share of $0.46.
Enterprise value:
530.7M
EV / Invested capital:
--
Price / LTM sales:
1.60x
EV / EBIT:
--
EV / Revenue:
2.09x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
14.05x
Price / Operating cash flow:
10.79x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$178.6M
Return On Assets:
-46.15%
Net Income Margin (TTM):
-132.39%
Return On Equity:
-163.61%
Return On Invested Capital:
-70.6%
Operating Margin:
25.87%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $299.2M | $348.6M | $254.3M | $67.8M | $78M | |
| Gross Profit | $199.4M | $257.4M | $178.6M | $46.9M | $60.2M | |
| Operating Income | -$9M | $49M | $9.1M | -$7.7M | $20.2M | |
| EBITDA | -$208.8M | -$196.2M | -$355.7M | -$260.5M | $22.1M | |
| Diluted EPS | -$9.07 | -$6.83 | -$8.10 | -$6.66 | $0.46 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $254M | $266M | $231.9M | $232.7M | $232.2M | |
| Total Assets | $1.7B | $1.7B | $1.3B | $987.1M | $665.5M | |
| Current Liabilities | $161.3M | $156.5M | $166M | $106.7M | $157.9M | |
| Total Liabilities | $686.5M | $646.3M | $626M | $523.7M | $516.3M | |
| Total Equity | $1B | $1.1B | $709.4M | $463.4M | $149.3M | |
| Total Debt | $271.9M | $270.8M | $277.2M | $278.9M | $257.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$4.4M | $1.3M | $43.7M | $1M | $15.5M | |
| Cash From Investing | -$2.4M | $3.8M | $3.2M | -$944K | -$1.7M | |
| Cash From Financing | -$8.7M | $624K | -$27.5M | $645K | -$105K | |
| Free Cash Flow | -$14M | -$4.5M | $37.8M | -$801K | $13.1M | |
CRNC
Sector
Market Cap
$395.8M
$83.5M
Price % of 52-Week High
33.27%
64.2%
Dividend Yield
0%
0%
Shareholder Yield
0.39%
0.68%
1-Year Price Total Return
185.05%
-12.88%
Beta (5-Year)
2.813
0.814
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$9.68
200-day SMA
Buy
Level
$8.53
Bollinger Bands (100)
Sell
Level
8.05 - 10.63
Chaikin Money Flow
Sell
Level
-2.5M
20-day SMA
Sell
Level
$9.56
Relative Strength Index (RSI14)
Sell
Level
46.59
ADX Line
Buy
Level
21.36
Williams %R
Buy
Level
-84.1945
50-day SMA
Sell
Level
$9.36
MACD (12, 26)
Buy
Level
0.06
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Sell
Level
-6.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.8287)
Sell
CA Score
(Annual)
Level (-3.2909)
Buy
Beneish M-Score
(Annual)
Level (-6.8281)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (5.3698)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
Stock Forecast FAQ
In the current month, CRNC has received 0 Buy ratings 5 Hold ratings, and 0 Sell ratings. The CRNC average analyst price target in the past 3 months is $11.60.
-
Where Will Cerence Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cerence share price will rise to $11.60 per share over the next 12 months.
-
What Do Analysts Say About Cerence?
Analysts are divided on their view about Cerence share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cerence is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is Cerence's Price Target?
The price target for Cerence over the next 1-year time period is forecast to be $11.60 according to 5 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is CRNC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cerence is a Hold. 5 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CRNC?
You can purchase shares of Cerence via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cerence shares.
-
What Is The Cerence Share Price Today?
Cerence was last trading at $9.51 per share. This represents the most recent stock quote for Cerence. Yesterday, Cerence closed at $9.15 per share.
-
How To Buy Cerence Stock Online?
In order to purchase Cerence stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
